Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. за авторством Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. за авторством Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. за авторством Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. за авторством Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. за авторством Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. за авторством Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. за авторством Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... за авторством Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. за авторством Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB. за авторством Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determ... за авторством Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB. за авторством Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determin... за авторством Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB. за авторством Diana M. Hendrickx (1507435)

Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study. за авторством Diana M. Hendrickx (1507435)

Graphical representations of the means of the variables length of stay, waiting time, treatment time, number of medical procedures performed, number of specialists involved in trea... за авторством Caro Fuchs (6278186)

Interview topic guide in English. за авторством Gislaine F. Bonella (15188236)

Предмети:

Active failures, error-producing and latent conditions (adapted from the Reason’s Accident Causation model) [21]. за авторством Gislaine F. Bonella (15188236)

Предмети:

Definitions used in Reason’s Accident Causation model” [21]. за авторством Gislaine F. Bonella (15188236)

Предмети:

Themes identified from the reports as latent conditions [21]. за авторством Gislaine F. Bonella (15188236)

Предмети: